Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

FDA approves oral semaglutide for reducing cardiovascular risks in adults with type 2 diabetes
Rybelsus from Novo Nordisk is officially the first oral GLP-1 drug approved for this indication. The FDA's decision was based on the SOUL trial, which included data from more than 9,000 patients with type 2 diabetes.
PET holds promise for carotid plaque assessments
PET has already gained significant momentum in recent years. Now, researchers are pointing to another possible use for the popular imaging modality: assessing carotid artery atherosclerosis.
New-onset AFib is common after CABG—but typically not persistent or symptomatic
The study's authors questioned if these patients should even be given oral anticoagulation as currently recommended.
Hospital in Mexico earns first heart failure certification of its kind
A facility outside the United States has received the American Heart Association's Comprehensive Heart Failure Center Certification for the first time.
Hypertrophic Cardiomyopathy Association supports study of potential treatment for nonbstructive HCM
No medications are currently approved for the treatment of nonobstructive hypertrophic cardiomyopathy. Could a new drug from Imbria Pharmaceuticals be the first?

Abbott FreeStyle Libre 2 glucose monitor

Abbott warns that device batteries may overheat or catch fire

The company emphasized that the issues are quite rare. No devices are being recalled, and it is not recommended that customers stop using them.

SCAI President Sunil Rao, MD, explains the 2022-2023 SCAI accomplishments to improve interventional cardiology.

SCAI President Sunil Rao on how the society is helping advance interventional cardiology

Rao spoke with Cardiovascular Business at ACC.23 to detail some of SCAI's biggest accomplishments from the last year.

Cardiologist Azeem Latib joins Supira Medical

The interventional cardiologist is now working with vendor Supira Medical to help advance the company's next-generation percutaneous ventricular assist device.

MRI scans suggest anti-amyloid drugs can cause accelerated brain volume loss

In some cases, certain classes of anti-amyloid beta (Aβ) drugs resulted in individuals’ brain volume decreasing more rapidly while using the drug than they would have if they had not received treatment at all.

Medtronic just launched its MRI Care Pathway, a new system that can streamline the process of completing MRI scans for patients with Medtronic MRI compatible cardiac devices.

Medtronic streamlines MRI screening, scanning for patients with implanted cardiac devices

Medtronic launched its MRI Care Pathway, a new system that can streamline the process of completing MRI scans for patients with compatible cardiac devices.

printable perovskite-based x-ray detector

Printable X-ray detectors are on the horizon

One benefit of these new detectors is that they can operate efficiently across multiple energy levels.

FDA announces third recall of 2023 for troubled heart devices

This latest recall is due to a heightened risk that the devices will stop working with no warning. There have been 42 customer complaints reported so far.

TAVR costs vary significantly from one hospital to the next

According to a new study of more than 119,000 hospitalizations, the costs associated with TAVR are far from consistent.

Clinical

FDA approves oral semaglutide for reducing cardiovascular risks in adults with type 2 diabetes

PET holds promise for carotid plaque assessments

New-onset AFib is common after CABG—but typically not persistent or symptomatic

Hospital in Mexico earns first heart failure certification of its kind

Hypertrophic Cardiomyopathy Association supports study of potential treatment for nonbstructive HCM